PTP inhibitor IV protects JNK kinase activity by inhibiting dual-specificity phosphatase 14 (DUSP14)

Biochemical and Biophysical Research Communications

Volumn 387, Issue 4, 2009, Pages 795-799

  Park, Jae Eun ^a   Park, Byoung Chul ^a   Song, Mina ^b   Park, Sung Goo ^a   Lee, Do Hee ^c   Park, So Young ^d   Kim, Jae Hoon ^e   Cho, Sayeon ^b  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Chung Ang University   (South Korea)

^c Division of Environmental and Life Sciences   (South Korea)

^d Korea University College of Medicine   (South Korea)

^e Jeju National University   (South Korea)

Author keywords

DUSP14; JNK; PTP inhibitor IV

Indexed keywords

BENZENE DERIVATIVE; BIS(4 TRIFLUOROMETHYLSULFONAMIDOPHENYL) 1,4 DIISOPROPYLBENZENE; DUAL SPECIFICITY PHOSPHATASE 14; METHYL GROUP; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; PROTEIN TYROSINE PHOSPHATASE INHIBITOR IV; STRESS ACTIVATED PROTEIN KINASE; SULFONAMIDE; UNCLASSIFIED DRUG;

ARTICLE; COMPETITIVE INHIBITION; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION;

CELL LINE; DUAL-SPECIFICITY PHOSPHATASES; ENZYME INHIBITORS; HUMANS; MAP KINASE KINASE 4; MITOGEN-ACTIVATED PROTEIN KINASE PHOSPHATASES; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; SULFONAMIDES;

EID: 68549126709     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.07.127     Document Type: Article

References (17)

1. Tonks N.K., and Neel B.G. Combinatorial control of the specificity of protein tyrosine phosphatases. Curr. Opin. Cell Biol. 13 (2001) 182-195
2. Zhang Z.Y. Protein tyrosine phosphatases: prospects for therapeutics. Curr. Opin. Chem. Biol. 5 (2001) 416-423
3. Alonso A., Sasin J., Bottini N., Friedberg I., Osterman A., Godzik A., Hunter T., Dixon J., and Mustelin T. Protein tyrosine phosphatases in the human genome. Cell 117 (2004) 699-711
4. Keyse S.M., and Ginsburg M. Amino acid sequence similarity between CL100, a dual-specificity MAP kinase phosphatase and cdc25. Trends Biochem. Sci. 18 (1993) 377-378
5. Tanoue T., Adachi M., Moriguchi T., and Nishida E. A conserved docking motif in MAP kinases common to substrates, activators and regulators. Nat. Cell. Biol. 2 (2000) 110-116
6. Tanoue T., Yamamoto T., and Nishida E. Modular structure of a docking surface on MAPK phosphatases. J. Biol. Chem. 277 (2002) 22942-22949
7. Davis R.J. Signal transduction by the JNK group of MAP kinases. Cell 103 (2000) 239-252
8. Johnson G.L., and Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298 (2002) 1911-1912
9. Herdegen T., and Waetzig V. AP-1 proteins in the adult brain: facts and fiction about effectors of neuroprotection and neurodegeneration. Oncogene 20 (2001) 2424-2437
10. Rincon M., Flavell R.A., and Davis R.J. Signal transduction by MAP kinases in T lymphocytes. Oncogene 20 (2001) 2490-2497
11. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 81 (2001) 807-869
12. Gallo K.A., and Johnson G.L. Mixed-lineage kinase control of JNK and p38 MAPK pathways. Nat. Rev. Mol. Cell. Biol. 3 (2002) 663-672
13. Loda M., Capodieci P., Mishra R., Yao H., Corless C., Grigioni W., Wang Y., Magi-Galluzzi C., and Stork P.J. Expression of mitogen-activated protein kinase phosphatase-1 in the early phases of human epithelial carcinogenesis. Am. J. Pathol. 149 (1996) 1553-1564
14. Fischer E.H., Charbonneau H., and Tonks N.K. Protein tyrosine phosphatases: a diverse family of intracellular and transmembrane enzymes. Science 253 (1991) 401-406
15. Huang P., Ramphal J., Wei J., Liang C., Jallal B., McMahon G., and Tang C. Structure-based design and discovery of novel inhibitors of protein tyrosine phosphatases. Bioorg. Med. Chem. 11 (2003) 1835-1849
16. Tierno M.B., Johnston P.A., Foster C., Skoko J.J., Shinde S.N., Shun T.Y., and Lazo J.S. Development and optimization of high-throughput in vitro protein phosphatase screening assays. Nat. Protoc. 2 (2007) 1134-1144
17. Marti F., Krause A., Post N.H., Lyddane C., Dupont B., Sadelain M., and King P.D. Negative-feedback regulation of CD28 costimulation by a novel mitogen-activated protein kinase phosphatase, MKP6. J. Immunol. 166 (2001) 197-206